In a major breakthrough in COVID-19 treatment, scientists in the United Kingdom have claimed that the generic steroid drug dexamethasone can improve the survival rate of COVID-19 patients.
The World Health Organisation (WHO) also approved the initial clinical trial results from the scientists that show dexamethasone can be life saving for critically ill COVID-19 patients. The benefit was only seen in critically ill COVID-19 patients, and was not observed in patients with milder symptoms.
“This is the first treatment to be shown to reduce mortality in patients with Covid-19 requiring oxygen or ventilator support,” said Dr Tedros Adhanom Ghebreyesus, WHO Director General.
Dexamethasone is a steroid that has been widely used in other diseases to reduce inflammation. The drug was given either orally or through an IV. However medical experts warn that the steroid cannot be used as preventive medicine. A full analysis about the potential of the drug will be researched in coming days.
By Joseph Maliakan You scratch an Indian, the caste comes out , irrespective of whether…
SRUTHI MATHAA… LAYA PITHAA… The International Chamber for Indian Music & Culture, an international initiative…
By Joseph Maliakan The Viksit Bharat Shiksha Adhishthan ( VBSA) ,Bill 2025 to replace the…
Kochi: A prominent NRI who is known for his corporate finance expertise and association with…
By Joseph Maliakan As a reporter who has witnessed the continuous erosion of academic freedoms…
KOCHI: The significance of the Comprehensive Economic Partnership Agreement (CEPA) as a catalyst to boost…
This website uses cookies.